pharmaphorum

NOVEMBER 19, 2020

Because Roche has never applied for Avastin to be used in wet AMD, clinics in the US have had to choose between the peace of mind offered by the regulatory process and Lucentis’ higher price tag, or the unapproved off-label formulation of Avastin at a lower price.

Biosimilars 64

Biosimilars Labelling 64

Pharmaceutical Technology

MAY 2, 2023

High-prescribing physicians surveyed by GlobalData across eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China) identified a broad range of unmet needs in the IO space (see Figure 1). Despite the significant advances that have been made in the IO field, a huge level of unmet need remains.

Immunity 52

Immunity Immunization Vaccines 52

PharmaShots

MARCH 9, 2023

She also concentrated on business globalization strengthening Merck’s position in the United States, Japan, and other high-growth markets. Belén Garijo also created two significant international collaborations that raised the value of the Healthcare business. LinkedIn Total experience: 29 yrs. LinkedIn Total experience: 16 yrs.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

Express Pharma

SEPTEMBER 11, 2023

This is required to be adhered to if Indian manufacturers wish to export their generic/ brand medicines to Developed Countries such as the EU, US, Japan, Canada, Australia, etc. B) WHO-GMP standards for soft-regulatory markets – These are good standards of quality, and standards are updated by WHO every two years.

Generic Medicine 69

Generic Medicine Diabetes Immunity Immunization 69

Pharmaceutical Technology

MARCH 17, 2023

In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”. Watt explained that for newer, first-in-class drugs these types of agreements can also give healthcare systems safety in their decisions to approve certain drugs. Click here to watch this webinar and access the presentation.

Communication 102

Communication Pharmaceutical Companies Pharmaceutical Companies 102

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Novo Nordisk is another company leading the charge in this field. In a Phase II study, CagriSema achieved a numerically higher body weight reduction of 15.6% compared to a 5.1%

Insurance Coverage and Processing 105

Insurance Coverage and Processing Diabetes Labelling Communication 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Novo Nordisk is another company leading the charge in this field. In a Phase II study, CagriSema achieved a numerically higher body weight reduction of 15.6% compared to a 5.1%

Insurance Coverage and Processing 98

Insurance Coverage and Processing Diabetes Labelling Communication 98